New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

Show other versions (1)

New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

Bibliographic Details
Main Author: article Editorial
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:https://www.rpcardio.com/jour/article/view/332
id doaj-30635a6d955446cfbb728e31cb1fc586
record_format Article
spelling doaj-30635a6d955446cfbb728e31cb1fc5862021-09-03T13:15:14ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-11-01115551552332New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillationarticle EditorialNew data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillationhttps://www.rpcardio.com/jour/article/view/332
collection DOAJ
language English
format Article
sources DOAJ
author article Editorial
spellingShingle article Editorial
New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
Racionalʹnaâ Farmakoterapiâ v Kardiologii
author_facet article Editorial
author_sort article Editorial
title New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_short New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_full New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_fullStr New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_full_unstemmed New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_sort new data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-11-01
description New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
url https://www.rpcardio.com/jour/article/view/332
work_keys_str_mv AT articleeditorial newdataoftherealclinicalpracticeconfirmslowincidenceofmajorbleedingwhenusingrivaroxabaninpatientswithnonvalvularatrialfibrillation
_version_ 1717817034005282816

Similar Items